微博
加入微博一起分享新鲜事
登录
|
注册
140
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted 212Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer https://www.theragnostics.no/en/publications/berner-2025-first-in-human/
请登录并选择要私信的好友
300
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted 212Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer https://www.theragnostics.no/en/publications/berner-2025-first-in-human/
赞一下这个内容
公开
分享
获取分享按钮
正在发布微博，请稍候